1 Arrested With Banned Drugs Worth Rs 5.22 Lakh From Valsad, Gujarat

Mira Bhayandar: Just under a month following the arrest of an individual caught with restricted drugs valued at Rs. 3.66 lakh in Kashimira, the Anti-Narcotics Cell (ANC) of the Mira Bhayandar-Vasai Virar (MBVV) police successfully traced the origin of the contraband to a commercial establishment situated in Valsad city, Gujarat, on Friday.

On September 18th, the ANC had apprehended a Mira Road resident found in possession of restricted drugs, including 300 bottles of cough syrup containing codeine phosphate and 10,800 tablets of Alprazolam. In the course of their investigations to determine the source of the contraband, the ANC managed to acquire a mobile number allegedly used by one of the suspects to communicate with buyers. Utilizing call data records and technical surveillance, the police located the accused’s phone to be active within the tower limits of Sethia Nagar in Valsad.

Promptly, ANC personnel led by PSI Santosh Ghadge rushed to Valsad and apprehended the accused. Subsequent intensive interrogations led the accused to disclose a larger consignment valued at over Rs. 5.22 lakh. This included 969 bottles of cough syrup containing codeine phosphate and 1,930 tablets of Alprazolam, both classified as scheduled drugs. The misuse and illegal sale of these drugs as narcotics are punishable under the provisions of the Narcotic Drugs and Psychotropic Substances (NDPS) Act of 1985.

Notably, stringent regulations govern the sale and purchase of such cough syrups, which are recognized as potent intoxicants. Nonetheless, numerous drug addicts consume these syrups to achieve a high. Moreover, unregistered suppliers allegedly distribute cough syrups and tablets to chemists who reportedly sell them at prices exceeding the maximum retail price, often without requiring the mandated prescription from a registered medical practitioner, according to sources.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?